Equine Reproductive Procedures 2014
DOI: 10.1002/9781118904398.ch46
|View full text |Cite
|
Sign up to set email alerts
|

Management of Seasonal Anestrus: Hormone Therapy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2020
2020
2020
2020

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 1 publication
0
1
0
Order By: Relevance
“…The exact mechanism of action of catecholamines, DA in particular, on follicular dynamics is not known, but is believed to involve the regulation of prolactin as its pituitary production, which primarily is regulated through inhibition by the neurotransmitter DA. The DA antagonist increases the circulating prolactin and estradiol concentrations after the first week of treatment, indicating a follicular development as a result of inhibition of DA and increased stimulation of gonadotrophin receptors on the ovary [ 36 ]. However, the DA antagonists allow follicular development only in the presence of FSH secretion and the ability of the ovary to respond to them in the mare.…”
Section: Discussionmentioning
confidence: 99%
“…The exact mechanism of action of catecholamines, DA in particular, on follicular dynamics is not known, but is believed to involve the regulation of prolactin as its pituitary production, which primarily is regulated through inhibition by the neurotransmitter DA. The DA antagonist increases the circulating prolactin and estradiol concentrations after the first week of treatment, indicating a follicular development as a result of inhibition of DA and increased stimulation of gonadotrophin receptors on the ovary [ 36 ]. However, the DA antagonists allow follicular development only in the presence of FSH secretion and the ability of the ovary to respond to them in the mare.…”
Section: Discussionmentioning
confidence: 99%